Skip to content
Search

Latest Stories

3 deaths linked to listeria outbreak; NHS staff advised to withdraw Cool Delight Desserts products

Four cases of listeria have been reported in England and one in Wales. FSA alert issued for recall of Cool Delight Desserts products from health care settings

Listeria outbreak: Cool Delight Desserts products removed from health care setting

The bacteria were detected in chocolate and vanilla and strawberry and vanilla flavoured mousse.

Cool Delight Desserts

NHS staff have been advised to remove all Cool Delight Desserts products from service and sales as a precautionary measure following the death of three people linked to a listeria outbreak.

The UK Health Security Agency (UKHSA) and Food Standards Agency (FSA) are investigating five cases of Listeria monocytogenes infection linked to the same strain of bacteria found in mousses supplied to NHS hospitals and care homes.


According to The Independent, the cases were identified between May and December 2024 and involved individuals aged 68 to 89 from North West England, Yorkshire and the Humber, the West Midlands, and Wales.

All affected individuals reportedly had underlying immunocompromising health conditions and were hospitalised.

While one death has been directly attributed to listeria, the other two were known to be infected at the time of their deaths.

Food alert issued

While the UKHSA has not yet confirmed the cause of the outbreak, they have identified a potential link to a particular type of dessert, which is served in some NHS Trusts.

The bacteria were detected in chocolate and vanilla and strawberry and vanilla flavoured mousse from Cool Delight Desserts last month. Both food samples were collected from an NHS hospital in the Southwest region of England, as part of their routine surveillance.

Although the detected levels were below the legal regulatory threshold, the FSA has issued an alert to recall all products under the brand (including ice cream, ice cream rolls, mousses and yoghurts) from health care settings as a precaution.

The alert received by the West Midlands Care Association cited the potential risk of Listeria monocytogenes contamination in these products.

“These products must all be withdrawn from service, and placed in quarantine while investigations are ongoing,” it said.

Where affected products have been received by a healthcare setting are required to confirm that the products have been withdrawn from service and when.

“Working with the Food Standards Agency, on a precautionary basis, we have advised NHS Trusts and those providing care to vulnerable people to stop serving these desserts while investigations are underway,” Dr Gauri Godbole, deputy director for gastrointestinal infections, food safety and one health at UKHSA told the publication.

Tina Potter, head of incidents at the FSA, confirmed that the affected desserts are currently being removed from the supply chain while investigations continue.

She said that the supplier is conducting a product withdrawal as a precaution while the cause of contamination is being investigated.

Listeria outbreak: Cool Delight Desserts products removed from health care settingIn rare cases, listeria can lead to serious complications such as meningitis and sepsis.Getty Images

Understand listeria

Listeria is a foodborne bacterium that causes listeriosis, a rare infection. In healthy adults and children, it typically results in mild or no symptoms. However, certain individuals are at a higher risk of developing severe illness, known as invasive listeriosis.

Dr Godbole warned that while most people with listeriosis experience mild symptoms such as diarrhoea, the infection can be severe or life-threatening in vulnerable individuals, including:

  • Immunocompromised patients
  • Older adults (65+)
  • Pregnant women and their unborn babies
  • Newborns up to one month old

Listeriosis symptoms can be similar to flus and may include:

  • High fever
  • Muscle aches and pains
  • Chills
  • Nausea and vomiting
  • Diarrhoea

In rare cases, listeria can lead to serious complications such as meningitis and sepsis.

Listeria is commonly found in the environment and can contaminate various foods, but it is most prevalent in ready-to-eat items.

A representative from Cool Delight Desserts told Food Safety News that the company was in ongoing discussions regarding the matter.

Meanwhile, the FSA, UKHSA, NHS and local authorities are working together to identify the cause of the outbreak.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less